Performance of BGNE BeiGene | -25.2% in 12m
Compare BGNE with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare BeiGene with its related Sector/Index XBI
Performance Duell BGNE vs XBI
| TimeFrame | BGNE | XBI |
|---|---|---|
| 1 Day | 1.06% | -1.52% |
| 1 Week | 7.27% | 3.45% |
| 1 Month | 31.1% | 7.71% |
| 3 Months | 16.6% | -2.11% |
| 6 Months | -7.51% | 25.51% |
| 12 Months | -25.2% | 6.37% |
| YTD | -2.34% | 1.05% |
| Rel. Perf. 1m | 1.63 | |
| Rel. Perf. 3m | -0.70 | |
| Rel. Perf. 6m | -4.19 | |
| Rel. Perf. 12m | -3.84 |
Is BeiGene a good stock to buy?
No, based on ValueRay Fundamental Analyses, BeiGene (NASDAQ:BGNE) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -53.02 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BGNE as of May 2024 is 151.17. This means that BGNE is currently overvalued and has a potential downside of -12.54% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BGNE as of May 2024 is 151.17. This means that BGNE is currently overvalued and has a potential downside of -12.54% (Sold with Premium).
Is BGNE a buy, sell or hold?
- Strong Buy: 14
- Buy: 5
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: BGNE is performing better - Values below 0%: BGNE is underperforming
Compare BGNE with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.62% | 25.32% | -25.80% | -54.52% |
| US NASDAQ 100 | QQQ | 5.08% | 25.00% | -24.98% | -62.52% |
| US Dow Jones Industrial 30 | DIA | 5.91% | 24.92% | -22.98% | -47.19% |
| German DAX 40 | DBXD | 7.67% | 26.12% | -24.50% | -41.94% |
| UK FTSE 100 | ISFU | 5.77% | 21.29% | -24.37% | -40.54% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.16% | 26.57% | -10.84% | -17.50% |
| Hongkong Hang Seng | HSI | 3.54% | 7.81% | -12.55% | -19.81% |
| Japan Nikkei 225 | EXX7 | 6.90% | 31.59% | -19.00% | -36.98% |
| India NIFTY 50 | INDA | 4.16% | 27.17% | -25.09% | -53.89% |
| Brasil Bovespa | EWZ | 6.83% | 25.85% | -5.68% | -37.50% |
BGNE BeiGene vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.27% | 27.78% | -26.02% | -62.65% |
| Consumer Discretionary | XLY | 6.93% | 27.39% | -14.85% | -44.84% |
| Consumer Staples | XLP | 6.51% | 24.51% | -21.75% | -30.75% |
| Energy | XLE | 6.07% | 30.21% | -21.63% | -50.39% |
| Financial | XLF | 5.69% | 24.04% | -29.93% | -58.24% |
| Health Care | XLV | 5.38% | 25.41% | -22.52% | -38.67% |
| Industrial | XLI | 7.55% | 27.61% | -27.20% | -53.50% |
| Materials | XLB | 6.93% | 27.55% | -23.53% | -45.79% |
| Real Estate | XLRE | 4.76% | 22.61% | -17.15% | -35.15% |
| Technology | XLK | 4.21% | 24.57% | -23.83% | -63.48% |
| Utilities | XLU | 5.77% | 18.20% | -25.71% | -37.85% |
| Aerospace & Defense | XAR | 6.50% | 22.63% | -23.05% | -49.32% |
| Biotech | XBI | 3.82% | 23.38% | -33.02% | -31.54% |
| Homebuilder | XHB | 7.59% | 24.75% | -38.02% | -76.02% |
| Retail | XRT | 5.19% | 23.63% | -28.35% | -50.36% |
Does BeiGene outperform its market, is BGNE a Sector Leader?
No, over the last 12 months BeiGene (BGNE) made -25.17%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.37%.
Over the last 3 months BGNE made 16.61%, while XBI made -2.11%.
No, over the last 12 months BeiGene (BGNE) made -25.17%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.37%.
Over the last 3 months BGNE made 16.61%, while XBI made -2.11%.
| Period | BGNE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 31.09% | 7.71% | 5.77% |
| 3 Months | 16.61% | -2.11% | 6.32% |
| 12 Months | -25.17% | 6.37% | 29.35% |